Works by Quick, Donald


Results: 30
    1
    2
    3
    4

    P882: POMALIDOMIDE, DARATUMUMAB, AND DEXAMETHASONE AFTER LENALIDOMIDE TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): FINAL OVERALL SURVIVAL ANALYSIS OF THE PHASE 2 MM‐014 STUDY.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970432.75766.0c
    By:
    • Bahlis, Nizar J;
    • Samaras, Christy;
    • Reece, Donna;
    • Sebag, Michael;
    • Matous, Jeffrey;
    • Berdeja, Jesus;
    • Shustik, Jesse;
    • Schiller, Gary;
    • Ganguly, Siddhartha;
    • Song, Kevin;
    • Seet, Christopher S.;
    • Acosta‐Rivera, Mirelis;
    • Quick, Donald;
    • Anz, Bertrand;
    • Fonseca, Gustavo;
    • Flores, Unicel‐Anne;
    • Liu, Hongjuan;
    • Gentili, Christian;
    • Siegel, David
    Publication type:
    Article
    5

    Pomalidomide, dexamethasone, and daratumumab immediately after lenalidomide-based treatment in patients with multiple myeloma: updated efficacy, safety, and health-related quality of life results from the phase 2 MM-014 trial.

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 6, p. 1407, doi. 10.1080/10428194.2022.2030477
    By:
    • Bahlis, Nizar J.;
    • Siegel, David S.;
    • Schiller, Gary J.;
    • Samaras, Christy;
    • Sebag, Michael;
    • Berdeja, Jesus;
    • Ganguly, Siddhartha;
    • Matous, Jeffrey;
    • Song, Kevin;
    • Seet, Christopher S.;
    • Acosta-Rivera, Mirelis;
    • Bar, Michael;
    • Quick, Donald;
    • Anz, Bertrand;
    • Fonseca, Gustavo;
    • Chung, Weiyuan;
    • Lee, Kim;
    • Mouro, Jorge;
    • Agarwal, Amit;
    • Reece, Donna
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    THE 1962 EPIDEMIC OF ST. LOUIS ENCEPHALITIS IN FLORIDA.

    Published in:
    American Journal of Epidemiology, 1966, v. 83, n. 3, p. 564, doi. 10.1093/oxfordjournals.aje.a120607
    By:
    • BOND, JAMES O.;
    • QUICK, DONALD T.;
    • LEWIS, ARTHUR L.;
    • HAMMON, WILLIAM McD;
    • SATHER, GLADYS E.
    Publication type:
    Article
    13
    14
    15
    16
    17

    Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B‐cell non‐Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306).

    Published in:
    British Journal of Haematology, 2020, v. 188, n. 2, p. 240, doi. 10.1111/bjh.16255
    By:
    • Pettengell, Ruth;
    • Długosz‐Danecka, Monika;
    • Andorsky, David;
    • Belada, David;
    • Georgiev, Pencho;
    • Quick, Donald;
    • Singer, Jack W.;
    • Singh, Simran B.;
    • Pallis, Athanasios;
    • Egorov, Anton;
    • Salles, Gilles
    Publication type:
    Article
    18

    Intracranial atherosclerotic disease: An update.

    Published in:
    Annals of Neurology, 2009, v. 66, n. 6, p. 730, doi. 10.1002/ana.21768
    By:
    • Qureshi, Adnan I.;
    • Feldmann, Edward;
    • Gomez, Camilo R.;
    • Johnston, S. Claiborne;
    • Kasner, Scott E.;
    • Quick, Donald C.;
    • Rasmussen, Peter A.;
    • Suri, M. Fareed K.;
    • Taylor, Robert A.;
    • Zaidat, Osama O.
    Publication type:
    Article
    19
    20

    Light-chain paraproteins with lupus anticoagulant activity.

    Published in:
    American Journal of Hematology, 1999, v. 62, n. 2, p. 99, doi. 10.1002/(SICI)1096-8652(199910)62:2<99::AID-AJH6>3.0.CO;2-N
    By:
    • Yasin, Zahida;
    • Quick, Donald;
    • Thiagarajan, Perumal;
    • Spoor, Denise;
    • Caraveo, Juan;
    • Palascak, Joseph
    Publication type:
    Article
    21
    22

    Pomalidomide/Daratumumab/Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Overall Survival From MM-014.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 12, p. 852, doi. 10.1016/j.clml.2024.07.014
    By:
    • Bahlis, Nizar J.;
    • Samaras, Christy;
    • Reece, Donna;
    • Sebag, Michael;
    • Matous, Jeffrey;
    • Berdeja, Jesús G.;
    • Shustik, Jesse;
    • Schiller, Gary J.;
    • Ganguly, Siddhartha;
    • Song, Kevin;
    • Seet, Christopher S.;
    • Acosta-Rivera, Mirelis;
    • Bar, Michael;
    • Quick, Donald;
    • Fonseca, Gustavo;
    • Liu, Hongjuan;
    • Gentili, Christian;
    • Singh, Pavit;
    • Siegel, David
    Publication type:
    Article
    23

    Pomalidomide/Daratumumab/Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Overall Survival From MM-014.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 12, p. 852, doi. 10.1016/j.clml.2024.07.014
    By:
    • Bahlis, Nizar J.;
    • Samaras, Christy;
    • Reece, Donna;
    • Sebag, Michael;
    • Matous, Jeffrey;
    • Berdeja, Jesús G.;
    • Shustik, Jesse;
    • Schiller, Gary J.;
    • Ganguly, Siddhartha;
    • Song, Kevin;
    • Seet, Christopher S.;
    • Acosta-Rivera, Mirelis;
    • Bar, Michael;
    • Quick, Donald;
    • Fonseca, Gustavo;
    • Liu, Hongjuan;
    • Gentili, Christian;
    • Singh, Pavit;
    • Siegel, David
    Publication type:
    Article
    24

    P-189: Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma (MM-014 phase 2 trial): a subanalysis of patients previously treated with lenalidomide and a proteasome inhibitor.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S141, doi. 10.1016/S2152-2650(21)02316-8
    By:
    • Bahlis, Nizar J.;
    • Schiller, Gary J.;
    • Sebag, Michael;
    • Berdeja, Jesus G.;
    • Ganguly, Siddhartha;
    • Matous, Jeffrey V.;
    • Song, Kevin;
    • Seet, Christopher;
    • Acosta-Rivera, Mirelis;
    • Bar, Michael;
    • Quick, Donald;
    • Anz, Bertrand M.;
    • Fonseca, Gustavo;
    • Reece, Donna E.;
    • Vogel, Prisca;
    • Kim Lee;
    • Weiyuan Chung;
    • Agarwal, Amit;
    • Siegel, David S.
    Publication type:
    Article
    25

    Health-Related Quality of Life With Pomalidomide + Dexamethasone + Daratumumab After Lenalidomide in Relapsed or Refractory Multiple Myeloma Patients.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e277, doi. 10.1016/j.clml.2019.09.457
    By:
    • Reece, Donna;
    • Bahlis, Nizar J.;
    • Samaras, Christy Joy;
    • Sebag, Michael;
    • Berdeja, Jesus;
    • Ganguly, Siddhartha;
    • Matous, Jeffrey;
    • Song, Kevin;
    • Seet, Christopher S.;
    • Talamo, Giampaolo;
    • Acosta-Rivera, Mirelis;
    • Bar, Michael;
    • Quick, Donald;
    • Anz, Bertrand;
    • Fonseca, Gustavo;
    • Agarwal, Amit;
    • Chung, Weiyuan;
    • Zafar, Faiza;
    • Siegel, David S.
    Publication type:
    Article
    26
    27
    28
    29
    30